Concurrent endometrial cancer in atypical endometrial hyperplasia and the role of sentinel lymph nodes: clinical insights from a multicenter experience.
Andrea RosatiVirginia VargiuVito Andrea CapozziDiana GiannarelliEmilia PalmieriAlessandro BaroniEmanuele PerroneRoberto BerrettaFrancesco CosentinoGiovanni ScambiaFrancesco FanfaniPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
This study found a prevalence of concurrent endometrial cancer of 47.2%, and sentinel lymph node biopsy provided prognostic and therapeutic information in 60.8% of cases. It also allowed for the adjustment of adjuvant therapy in 12.3% of high to intermediate-risk patients without increasing operative time or complication rates.
Keyphrases
- endometrial cancer
- sentinel lymph node
- lymph node
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- early stage
- ejection fraction
- neoadjuvant chemotherapy
- locally advanced
- prognostic factors
- healthcare
- clinical trial
- squamous cell carcinoma
- health information
- patient reported outcomes
- rectal cancer
- radiation therapy
- ultrasound guided
- double blind